Earnings
Soluna Q2 2026 revenue jumps 145% but profit margins shrink
Strong top-line growth fails to offset rising costs, leaving net income under pressure despite a near-3x revenue increase.
Jefferson Capital Q2 2026 profit beats estimates on higher revenue
Consumer credit firm Jefferson Capital reported second-quarter 2026 earnings that exceeded analyst forecasts, driven by revenue growth in its debt purchasing and servicing segments.
Stardust Power posts narrower-than-expected Q2 2026 loss
Solar component manufacturer Stardust Power reported a smaller-than-anticipated second-quarter loss for 2026, beating analyst estimates despite ongoing pricing pressures.
Veritone Q2 2026 earnings miss sends shares down 23%
AI-driven data analytics firm Veritone reported Q2 2026 results below Wall Street forecasts, prompting a sharp selloff in shares amid broader tech sector weakness.
XBP Global Q2 2026 profit rises despite revenue shortfall
Second-quarter earnings beat expectations on cost controls, while top-line growth lagged forecasts amid market headwinds.
DLocal revenue beats estimates in Q2 2026, earnings fall short
Latin American fintech firm DLocal reported Q2 2026 revenue above expectations but earnings per share missed analyst forecasts amid rising costs.
Soluna shares drop after Q2 2026 revenue beats forecasts
Revenue surge of over 40% in Q2 2026 fails to lift Soluna stock amid broader market skepticism.
AmpliTech Group shares slump after Q2 2026 revenue miss
Second-quarter revenue fell short of expectations, triggering a steep decline in the company's stock price.
Clene misses earnings by 75 cents per share, revenue beats forecasts
Biopharma firm Clene reported adjusted EPS of -$0.15 versus a -$0.90 estimate, while revenue reached $12.3 million, above the $11.8 million consensus.
Kyntra Bio shares rise on pipeline updates despite weak Q2 2026 sales
Biotech firm Kyntra Bio gains after positive pipeline progress offsets a 12% decline in quarterly sales, with analysts citing long-term potential.
Blaize lowers 2026 revenue forecast despite Q2 revenue surge
Quarterly revenue rose sharply, but management trimmed long-term growth expectations citing macroeconomic uncertainty.
HeartFlow Q2 2026 EPS beats estimates, shares surge 17%
Medical imaging firm HeartFlow reported adjusted earnings per share above Wall Street forecasts for Q2 2026, driving a sharp rise in its stock price.
Laird Superfood Q2 2026 revenue beats estimates, shares surge
Plant-based food company Laird Superfood reported second-quarter 2026 revenue above Wall Street expectations, lifting its shares 12% in extended trading.
Health In Tech misses Q2 2026 profit view, shares drop
Health In Tech reported second-quarter 2026 earnings below expectations, sending shares lower as investors reassessed growth prospects in the sector.
Nektar misses Q2 2026 EPS despite beat; stock slips in after-hours trade
Biopharmaceutical firm Nektar Therapeutics reported adjusted earnings per share above estimates but fell short on revenue. The stock declined in extended trading despite the EPS beat.
Midera Food Processing lifts 2026 outlook after Q2 results
Company raises full-year guidance following stronger-than-expected quarterly earnings. Shares rise on improved forecast.
StoneCo Q2 2026 revenue misses estimates in mixed results
Brazilian fintech StoneCo reported mixed second-quarter results for 2026, with revenue falling short of analyst expectations despite gains in key business segments.
KinderCare Q2 2026 EBITDA falls as enrollment declines
Early slides for KinderCare’s second-quarter 2026 outlook show EBITDA pressure tied to lower enrollment, with financial metrics flagged ahead of formal results.
NextPlat Q2 2026 loss narrows as shares surge 21%
Loss reduction beats expectations as stock surges on earnings call optimism. Company cites operational improvements and cost controls.
Avalanche One reports Q2 2026 revenue surge, shares rise after hours
Avalanche One's Q2 2026 earnings call highlights a sharp revenue increase, with shares climbing in after-hours trading. Key figures and outlook discussed.
AudioEye Q2 2026 revenue exceeds estimates, shares up 2.2%
Digital accessibility firm AudioEye reported second-quarter 2026 revenue above analyst expectations, driving a 2.2% intraday gain in its shares.
Intermap Q2 2026 loss widens on Indonesia delays
Intermap Technologies reported a wider second-quarter loss for 2026 as project delays in Indonesia weighed on revenue and increased operating costs.
TSS Inc. misses Q2 2026 revenue forecast, shares fall
Revenue came in below guidance as TSS Inc.'s Q2 2026 results disappointed investors, sending shares lower in after-hours trading.
Applied Materials Q3 2026 earnings beat, shares decline
Semiconductor equipment maker Applied Materials posted quarterly results above Wall Street forecasts but saw its stock drop on guidance and broader sector concerns.